Abstract:ABSTRACT Biotherapeutic strategies to promote health, including the application of engineered microbes to deliver therapeutic molecules, hold strong promise. However, without precision tools to detect therapeutic microbes and their products, we are hampered in our ability to monitor and fine-tune therapeutic delivery. Here, we adapted a bioluminescent peptide tagging system for use in lactic acid bacteria, a group of organisms whose members are commonly exploited as delivery vehicles of therapeutics and vaccines. As a proof of concept, we developed various Limosilactobacillus reuteri strains that each produced a recombinant therapeutic protein with an 11 amino acid tag, which is essential to yield a luminescent signal. Luminescent-based quantification of recombinant protein was more sensitive than commercially available immunoassays. In addition, we demonstrated that the bioluminescent peptide tagging system allows in situ recombinant protein detection in a continuous-culture parallel bioreactor system. This presents an exciting opportunity to determine recombinant protein production dynamics in response to different stimuli. Finally, following oral administration of recombinant microbes, luminescence in intestinal and fecal samples allowed for rapid detection of microbes with equal sensitivity to conventional plate count. Because we demonstrated the functionality of this bioluminescent peptide tagging system in 12 species encompassing nine genera , our approach will create previously unexplored opportunities in lactic acid bacteria research. IMPORTANCE Lactic acid bacteria constitute a genetically diverse group of microorganisms with significant roles in the food industry, biotechnology, agriculture, and medicine. A core understanding of bacterial physiology in diverse environments is crucial to select and develop bacteria for industrial and medical applications. However, there is a lack of versatile tools to track (recombinant) protein production in lactic acid bacteria. In this study, we adapted a peptide-based bioluminescent tagging system that is functional across multiple genera and species. This system enables tracking of tagged proteins both in vitro and in situ , while it also can be used to enumerate recombinant bacteria from the mouse gastrointestinal tract with accuracy comparable to that of conventional plate counts. Our work expands the lactic acid bacteria genetic toolbox and will facilitate researchers in industry and academia with opportunities to monitor microbes and proteins under different physiologically relevant conditions.

Generation and characterization of a Leishmania tarentolae strain for site-directed in vivo biotinylation of recombinant proteins

A non-commercial approach for the generation of transgenic Leishmania tarentolae and its application in antileishmanial drug discovery

A novel chemically defined medium for the biotechnological and biomedical exploitation of the cell factory Leishmania tarentolae

Systematic identification of genes encoding cell surface and secreted proteins that are essential for in vitro growth and infection in Leishmania donovani

Galactokinase-like protein from Leishmania donovani : Biochemical and structural characterization of a recombinant protein

Co-expression of human sialyltransferase improves N-glycosylation in Leishmania tarentolae and optimizes the production of humanized therapeutic glycoprotein IFN-beta

A one‐process production of completely biotinylated proteins in a T7 expression system

Expression and purification of an engineered, yeast-expressed Leishmania donovani nucleoside hydrolase with immunogenic properties

Development of Lyophilized Eukaryotic Cell-Free Protein Expression System Based on Leishmania tarentolae

Biochemical and biophysical characterization of Leishmania donovani citrate synthase

Identification, characterization, and cellular localization of Leishmania major CTP:phosphocholine cytidylyltransferase

Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases

Leishmania Chagasi: A Tetracycline-Inducible Cell Line Driven by T7 Rna Polymerase

Expanding the Scope of Genetically Encoded Lysine PTMs with Lactylation, β‐Hydroxybutyrylation and Lipoylation

Development of a semi-automated image-based high-throughput drug screening system

A Proteogenomic Approach to Unravel New Proteins Encoded in the Leishmania donovani (HU3) Genome

Bioluminescent monitoring of recombinant lactic acid bacteria and their products

Expanding the Scope of Genetically Encoded Lysine Post-Translational Modifications with Lactylation, -Hydroxybutyrylation and Lipoylation

A Targeted and Protease-Activated Genetically Encoded Melittin-Containing Particle for the Treatment of Cutaneous and Visceral Leishmaniasis

Genetically Encoded Biotin Analogues: Incorporation and Application in Bacterial and Mammalian Cells

Genetic validation of Leishmania genes essential for amastigote survival in vivo using N-myristoyltransferase as a model